baber/WOPTO huggingface dataset:
Patent JP-2722132-B2 (JP)
IPC: A61M29/02
Filed: 1990-04-26
Granted: 1998-03-04
Abstract: An instrument for and method of effectively treating the prostatic urethra so as to relieve the symptoms associated with an enlarged urethra is disclosed. The tissue of at least selected portions of the prostate are compressed (preferably with a balloon inserted into the prostatic urethra so as to enhance hemostasis) and at least selected portions of the compressed tissue are directly irradiated (preferably with a laser beam transmitted from within the passageway in selected radial directions and moved along the prostatic urethra while exposing the tissue) so as to cause coagulation necrosis of selected portions of the compressed tissue so that as the tissue heals, the necrosed tissue slowly sloughs off during normal urination through the urinary tract so as to effectively remove the constricted portions of the prostatic urethra. Ultrasonic transducers are used from within the prostatic urethra to image the tissue as it is irradiated so as to monitor the procedure to insure proper exposure to the laser beam.
Patent JP-3319596-B2 (JP)
IPC: A01K67/027
Filed: 1991-05-08
Granted: 2002-09-03
Abstract: This invention provides isolated nucleic acid molecules encoding human 5-HT1D receptors, isolated proteins which are human 5-HT1D receptors, vectors comprising isolated nucleic acid molecules encoding human 5-HT1D receptors, mammalian cells comprising such vectors, antibodies directed to the human 5-HT1D receptors, nucleic acid probes useful for detecting nucleic acid encoding human 5-HT1D receptors, antisense oligonucleotides complementary to any sequences of a nucleic acid molecule which encodes a human 5-HT1D receptor, pharmaceutical compounds related to human 5-HT1D receptors, and nonhuman transgenic animals which express DNA a normal or a mutant human 5-HT1D receptor. This invention further provides methods for determining ligand binding, detecting expression, drug screening, and treatment involving the human 5-HT1D receptor.
Patent JP-3802931-B2 (JP)
IPC: B65H33/08
Filed: 1996-09-18
Granted: 2006-08-02
Abstract: PCT No. PCT/FR96/01447 Sec. 371 Date Mar. 31, 1998 Sec. 102(e) Date Mar. 31, 1998 PCT Filed Sep. 18, 1996 PCT Pub. No. WO97/11438 PCT Pub. Date Mar. 27, 1997A method for storing a plurality of electronic smart cards each comprising a card body with a front surface and a rear surface, as well as an electronic module arranged in a recess in the front surface of the card body. The cards are stacked in series so as to be arranged in a number P of different directions such that the electronic module of a card having rank n is facing the rear surface of the card having rank n+P, while the front surface of the card having rank n and the rear surface of the card having rank n+P are separated by an air space with a thickness that is P-1 times that of the card body.
Patent JP-4389005-B2 (JP)
IPC: G01N33/493
Filed: 1994-10-19
Granted: 2009-12-24
Abstract: A method of monitoring compliance of a patient that has been placed on a medication maintenance program with a prescribed medication dosage by determining a normalized urine medication concentration. An unadulterated urine sample is obtained from the patient. The urine medication concentration and urine specific gravity are measured. The normalized urine medication concentration is calculated as a function of the measured medication concentration in the urine and the urine specific gravity. The calculated normalized urine medication concentration is compared with an expected medication concentration value for the patient for the maintenance program prescribed to determine any significant differences therebetween as an indication of noncompliance. Alternatively, a urinary-parameter normalized urine medication concentration is calculated as a function of the measured medication concentration in the urine, the urine specific gravity and at least one selected pharmacokinetic parameter of the medication. The calculated urinary-parameter normalized urine medication concentration is compared with an expected medication concentration value for an average compliant patient for the maintenance program prescribed to determine any significant differences therebetween as an indication of noncompliance.
Patent JP-3788517-B2 (JP)
IPC: A61K6/06
Filed: 1996-12-06
Granted: 2006-06-21
Abstract: Novel fillers comprising combeite glass-ceramic are provided. hardenable restorative compositions comprising particulate combeite glass-ceramic provide improved biocompatibility in bone restorations. Hard, shaped bodies for orthopaedic, dental and other uses are also provided.
Patent JP-4142108-B2 (JP)
IPC: A61B1/005
Filed: 1997-10-29
Granted: 2008-08-27
Abstract: An aneurism patch apparatus for treating an aneurism formed in a vessel includes a vessel interface side and an opposing non-interface side. A patch is formed of a sufficiently flexible material to provide a patch stowed state when the patch is delivered through the vessel and a patch deployed state when the patch is at least partially positioned over the mouth of the aneurism. The interface side of the patch is configured to form an adherence between the patch and an area of a vessel wall adjacent to the aneurism mouth. The adherence maintains a fixed position of the patch relative to the aneurism mouth.
Patent JP-3279318-B2 (JP)
IPC: A61K9/16
Filed: 1995-03-21
Granted: 2002-04-30
Abstract: A sustained-release excipient for use in oral solid dosage forms includes from about 15 to about 30 percent or more by weight heteropolysaccharide gum; an effective amount of a cationic cross-linking agent capable of cross-linking the heteropolysaccharide in an environment of use; and an inert pharmaceutical filler.
Patent ES-2223294-B2 (ES)
Inventor: PUIG SALVADOR
IPC: C07D281/16
Filed: 2003-08-08
Granted: 2005-10-01
Abstract: The invention relates to a procedure for preparing quetiapine by reaction between a compound of formula (II) and a compound of formula (III), in which X means a leaving group and P a protective group of alcohols resistant to alkaline conditions, in the presence of a base, followed by a step of deprotection and, optionally, obtaining a pharmaceutically acceptable salt thereof. Said procedure permits the obtaining of quetiapine with a high degree of purity under soft temperature conditions, with short reaction times and avoiding the use of toxic solvents. (Graphic)
Patent ES-2415251-B2 (ES)
Title: Sistema de aprovechamiento de la radiación reflejada en instalaciones fotovoltaicas
Inventor: GOMEZ ESTEBAN FERNANDO
IPC: H01L31/042
Filed: 2011-04-12
Granted: 2014-09-01
Abstract: Se describe un sistema que permite un aprovechamiento parcial de la radiación solar reflejada desde el suelo por los paneles solares de una instalación fotovoltaica. El sistema prevé la formación de una mezcla a base de materiales residuales y subproductos de vidrio y espejo, de diferentes tipos y coloraciones, fragmentados con una granulometría comprendida dentro de una gama predeterminada, con la que se extiende una capa sobre la superficie del suelo del campo de la instalación fotovoltaica, sobre la que incide la luz solar y se refleja con distintos ángulos, alcanzando la superficie de los paneles e incrementando la cantidad global de radiación incidente sobre los mismos.
Patent ES-2512965-B2 (ES)
Title: Sistema y método para escanear una superficie y programa de ordenador que implementa el método
Inventor: ROYO ROYO SANTIAGO
IPC: G01S17/931
Filed: 2013-02-13
Granted: 2015-11-24
Abstract: Sistema y método para escanear una superficie y programa de ordenador que implementa el método.#El sistema comprende:- medios para iluminar, con un haz de luz (Be), diferentes sub-áreas (Si) de una superficie (S), de manera alternada, y#-- medios para recibir y detectar las porciones de luz reflejada (Br) en las mismas, que incluyen:#- uno o más detectores de luz (D); y#- unos medios de redirección de luz que incluyen una cuadrícula (Qr) de elementos de redirección de luz (GM), que reciben las porciones de luz reflejada (Br) y las redirigen, de manera secuencial, hacia el detector o detectores de luz (D).#El método está adaptado para realizar las funciones llevadas a cabo por el sistema de la invención.#El programa de ordenador implementa el método de la invención.
Patent ES-2596856-B2 (ES)
Title: Carretilla elevadora, aerotransportable y procedimiento de estiba
Inventor: GARCES JIMENEZ JOSE ANTONIO
IPC: B66F9/075
Filed: 2016-07-08
Granted: 2017-08-10
Abstract: Carretilla elevadora, aerotransportable y procedimiento de estiba.#Carretilla elevadora, capaz de ser transportada en un avión Airbus A400 o superior, con capacidad de subir/bajar la rampa del avión, sin necesidad de utilizar apoyos o apuntalamientos, tanto en la posición de estiba, en el compartimento del avión, como en las operaciones de subida y bajada por medio de rampas auxiliares, conservando la integridad estructural de la máquina, cumpliendo con los limites admisibles de peso máximo por eje, en función de la distancia entre los mismos, para lo cual, dicha carretilla elevadora comprende un contrapeso (6) abatible, previsto para la distribución del peso en el eje trasero (3) y medios de bloqueo/desbloqueo, entre el mástil (4) y el chasis (1) previstos para la distribución del peso en el eje delantero (2), quedando reducido el peso por eje, por debajo de los límites establecidos en el compartimento de carga del avión.
Patent IE-S86602-B2 (IE)
Title: An injectable antibody preparation for use in reducing or maintaining previously reduced cholesterol level
Inventor: CLUBE JASPER
IPC: A61K39/00
Filed: 2014-11-07
Abstract: An injectable preparation comprising an antibody or antibody fragment, for use in reducing cholesterol level or maintaining previously reduced cholesterol level in humans. The antibody or fragment of the preparation comprises a VH domain derived from the recombination of a human VH gene segment, a human D gene segment, and a human JH gene segment. The human VH gene segment encodes the framework 1 of SEQ ID NO: 40. The antibody or fragment specifically binds a proprotein convertase subtilisin/kexin type 9 (PCSK9) amino acid sequence that comprises a C-terminal domain comprising a mutation I474V in SEQ ID NO: 1. The human comprises a nucleotide sequence encoding a PCSK9 comprising a mutation I474V in SEQ ID NO: 1. The human further comprises a VH gene segment encoding the framework 1 of SEQ ID NO: 40.
Patent IE-S86738-B2 (IE)
Title: Method of production of a cylinder for a fluid transfer device
Inventor: GONG ZHU
IPC: F04B1/00
Filed: 2015-09-10
Abstract: The invention relates to a design method for the cylinder. The method comprises providing a cylindrical valve chamber passing through the cylinder; arranging the receiving chamber radial with respect of the valve chamber, providing the receiving chamber with a cylindrical portion and a trumpet-shaped constriction portion coaxial with the cylindrical portion, arranging for the diameter of the head end of the constriction portion to be less than the interior diameter of the receiving chamber, communicating the tail ends of the receiving chamber, the input and passages with the valve chamber, arranging for the width of the tail end of the constriction portion to be greater than the width of the swinging range of the first passage, arranging for the minimal distance between the tail ends of the output and input passages to be greater than the width of the second passage. The cylinder of the invention achieves that fluid flows in one direction, and easy to mount, working steadily and reasonable stress. <Figure 5>
Patent AU-2001257019-B2 (AU)
Title: An improved method and system for conducting secure payments over a computer network
Inventor: CAMPBELL CARL M JR
IPC: G06Q20/00
Filed: 2001-04-11
Granted: 2007-06-21
Abstract: A method is provided for conducting a financial transaction by a purchaser with a merchant having an acquirer bank, over a communications network. The method includes the steps of sending a first authorization request using a pseudo account number associated with a real account number to a service provider which forwards a second authorization request to the issuer using the real account number and preferably a pseudo acquirer code associated with the service provider such that the response to the second request is based on the real account number and sent back to the service provider who preferably forwards a response to the first request preferably to the "real" acquirer. A message authentication code is further provided which includes transaction data, and where the authorization request if formatted as a standard payment card track having one or more fields including a discretionary field in which the message authentication code is placed.
Patent AU-2002243104-B2 (AU)
Title: A method and a system for distribution of fluidsable materials
Inventor: KARLSEN MORTEN
IPC: B65G53/20
Filed: 2002-03-20
Granted: 2007-01-04
Abstract: A method and a system distribute fluidizable materials from a reservoir of materials to one or more material receiving units. The distribution system has at least two hydraulic levels between the reservoir and the material receiving units. The system further includes a fluidizing element with good dynamic response properties. The system can be used for distribution of alumina and/or fluoride to feeding equipment in electrolysis cells with a reduced consumption of fluidizing gas.
Patent AU-2002257459-B2 (AU)
Title: 1-biaryl-1,8-napthyridin-4-one phosphodiesterase-4 inhibitors
Inventor: HAMEL PIERRE
IPC: A61P25/00
Filed: 2002-05-22
Granted: 2006-12-14
Abstract: Compounds represented by Formula (I):or a pharmaceutically acceptable salt thereof, are phosphodiesterrase 4 inhibitors useful in the treatment of asthma and inflammation.
Patent AU-2002339159-B2 (AU)
Title: Treatment of micro-organism infection
Inventor: MATTHEWS RUTH CHRISTINE
IPC: A61K45/00
Filed: 2002-11-13
Granted: 2008-06-05
Abstract: A medicament comprising a therapeutically effective quantity of daptomycin and an antibody. The antibody is specific against the epitope displayed by the peptide having the amino acid sequence of SEQ. ID NO: 3.
Patent AU-2003207323-B2 (AU)
Title: A method of selectively producing male or female sterile plants
Inventor: VINER RUSSELL
IPC: A01N57/20
Filed: 2003-02-14
Granted: 2007-09-13
Abstract: A method of producing male or female sterile plants comprising the steps of transforming plant material with a polynucleotide which encodes at least one enzyme which reacts with a non-phytotoxic substance to produce a phytotoxic one, and regenerating the thus transformed material into a plant, wherein the said non-phytotoxic substance is applied to the plant up to the time of male or female gamete formation and/ or maturation, so that the non-phytotoxic substance provides for the production of a phytotoxic one which selectively prevents the formation of or otherwise renders the said gametes non-functional, wherein the enzyme is expressed preferentially in either male or female reproductive structures,  characterised in that  (i) the non-phytotoxic substance is selected from the group consisting of ester derivatives of non-phosphonate herbicides which herbicides are directly phytotoxic to non-green tissue, D-alpha amino acids, peptide derivatives of non-protein D-alpha amino acids, S-enantiomers of aryloxyphenoxypropionates and S-enantiomers of ester derivatives of aryloxyphcnoxypropionatcs and (ii) the enzyme is selected from the group consisting of carboxylesterases, D-amino acid oxidases, D-amino acid dehydrogenases, D-amino acid racemases, 2-arylpropionyl-CoA epimerases, alpha-methylacyl-CoA racemases, thioesterases and acyl-CoA synthetases.
Patent AU-2003243968-B2 (AU)
Title: Method of photodynamic diagnosis for vascular diseases
Inventor: NAKAJIMA SUSUMU
IPC: A61K31/409
Filed: 2003-06-25
Granted: 2008-01-31
Abstract: Various diagnostics with the application of photodynamic di-agnosis/therapy (photodynamic therapy: PDT) wherein use is made of highly selective uptake of an iminochlorinaspartic acid derivative or its pharmacologically acceptable salt in neovessels and selective uptake thereof in cancer cells. More specifically, remedies for rheumatism, remedies for inflammatory keratosis, agents for confirming the location of a sentinel lymph node and diagnostics for cancer metastasis which contain as the active ingredient an iminochlorinaspartic acid derivative represented by the following formula (I) or its pharmacologically acceptable salt: (I) wherein Asp represents aspartate.
Patent AU-2004278042-B2 (AU)
Title: LPA receptor agonists and antagonists and methods of use
Inventor: DURGAM GANGADHAR G
IPC: A61K/
Filed: 2004-10-12
Granted: 2012-02-09
Abstract: The present invention relates to compounds according to formula (I) as disclosed herein as well as pharmaceutical compositions which include those compounds. Also disclosed are methods of using such compounds, which have activity as agonists or antagonists of LPA receptors; such methods including inhibiting LPA activity on an LPA receptor, modulating LPA receptor activity, treating cancer, enhancing cell proliferation, treating a would, treating apoptosis or preserving or restoring function in a cell, tissue or organ, culturing cells, preserving organ or tissue function, and treating a dermatological condition.
Patent AU-2004312923-B2 (AU)
Title: Systems and methods for direct navigation to specific portion of target document
Inventor: KRISHNA BHARAT
IPC: G06F17/30
Filed: 2004-12-29
Granted: 2012-01-12
Abstract: Systems and methods for direct navigation to and/or highlighting a specific portion of a target document such as query-relevant portion of the document are disclosed. The method may include generating a search result link to a search result document and generating an instruction to a client document browser to navigate directly to an intra-document portion related to the query within the search result document. The search result may include a snippet extracted from the search result document such that the instruction causes navigation directly to at least a portion of the snippet. The instruction may be an artificial anchor undefined in the search result document, e.g., designated by a preassigned artificial anchor designator. The client browser may have an artificial anchor module installed to execute the instruction to navigate directly to and optionally highlight the intra-document portion within the target document in response to the document link being selected.
Patent AU-2005206292-B2 (AU)
Title: Chimpanzee adenovirus vaccine carriers
Inventor: ALFREDO NICOSIA
IPC: C12N15/86
Filed: 2005-01-18
Granted: 2011-09-29
Abstract: The present invention provides recombinant replication-defective adenoviral vectors derived from chimpanzee adenoviruses and methods for generating recombinant adenoviruses in human E1-expressing cell lines. The invention also provides compositions and methods suitable for use for the delivery and expression of transgenes encoding immunogens against which a boosted immune response is desired. The invention further provides methods of generating clinical grade vector stocks suitable for use in humans. In a particular embodiment the invention contemplates the use of vectors comprising transgenes which encode tumor associated antigens in vaccines and pharmaceutical compositions for the prevention and treatment of cancer.
Patent AU-2005223622-B2 (AU)
Title: Lysozyme-chitosan films
Inventor: DAESCHEL MARK A
IPC: A23L29/275
Filed: 2005-03-17
Granted: 2010-05-27
Abstract: One aspect of the disclosure herein contemplates a composite film comprising lysozyme incorporated within a chitosan polymer matrix. In another aspect, there is disclosed a film that includes chitosan, and about 10 to about 200 weight percent lysozyme, based on the weight of the chitosan. Also disclosed is a method for making a film that includes dissolving or dispersing chitosan and lysozyme in an aqueous medium resulting in a film-forming solution or dispersion; applying the film-forming solution or dispersion to a substrate surface; and converting the film-forming solution or dispersion into a film. In a particularly useful application, the film is an antimicrobial protectant for a food article.
Patent AU-2005224665-B2 (AU)
Title: Remedial heap treatment
Inventor: SEAL THOMAS JOSEPH
IPC: E21B43/26
Filed: 2005-03-18
Granted: 2011-09-01
Abstract: A system and method are disclosed for improving component extraction from heap leach operations. Following heap leaching for some time, portions of the heap deficient in component extraction are identified, and treatment wells are drilled and remedial treatments are selectively performed on the identified portions of the heap. The remedial treatment can include hydraulically fracturing the identified portions of the heap followed by selective treatment with leach solution of the area impacted by the fracturing.
Patent AU-2005240230-B2 (AU)
Title: Device for winding and unwinding of hoses, cables or the like
Inventor: DETHIER LIVIN FERNAND GEORGES
IPC: B65H75/36
Filed: 2005-05-03
Granted: 2011-02-03
Abstract: Device for winding and unwinding hoses, cables or the like, which device (1) mainly consists of a wheeled undercarriage (2) with a support (6), whereby suspension means (9) are provided on the above-mentioned support (6) in the shape of at least two fixed guides (10 and 11), which are each made in the shape of a bent element (12), and whereby these bent elements (12) are directed with their hollow sides towards each other, whereby the above-mentioned bent elements (12) are confined by at least one upward or downward directed partition (13) which is practically parallel to the support (6) and whereby intermediate partitions (14) are provided on these elements (12) as well.
Patent AU-2005327862-B2 (AU)
Title: Volumetric rotary machine with rotors having asymmetric profiles
Inventor: GOEPFERT OLIVIER
IPC: F04C18/16
Filed: 2005-02-16
Granted: 2011-06-02
Abstract: Rotary displacement machine having a housing and at least two twinned rotors of asymmetrical profile, the twinned rotors each made of a core on which projects a helicoidal thread which extends above the core like a tooth. The helicoidal thread having a first predetermined dimension in a direction radial to the longitudinal axis of the twinned rotors and above the surface of a rotor. The machine having a first flank with a position and length of arc predetermined such that the shape of the first flank and the shape of the second flank each connect to one of the opposite ends of a connecting segment which constitutes a helicoidal surface. The connecting segment having a second predetermined dimension in a direction radial to the longitudinal axis of the twinned rotors such that the ratio of the second dimension over the first dimension ranges between 0.005 and 0.1.
Patent AU-2005336093-B2 (AU)
Title: Adoptive immunotherapy with enhanced T lymphocyte survival
Inventor: ROSENBERG STEVEN A
IPC: A61K39/00
Filed: 2005-10-07
Granted: 2011-02-24
Abstract: The invention provides for compositions, e.g., pharmaceutical compositions, comprising a T lymphocyte, or a population thereof, expressing at least one recombinant polynucleotide encoding a cytokine that enhances T lymphocyte survival during the contraction phase of an immune response. The invention further provides an isolated T lymphocyte, or population thereof, expressing at least one recombinant polynucleotide encoding the cytokine, wherein the polynucleotide comprises a non-native coding sequence encoding the cytokine. Also provided is the use of such compositions and T lymphocytes, or populations thereof, for the treatment or prevention of a medical condition e.g., cancer. A method of preparing the a T lymphocyte with enhanced T cell survival is further provided herein.